Type 2 Diabetes

Based on the current number of cases of non-alcoholic steatohepatitis in the United States, more than $175 billion will be spent on managing and treating the disease, two-thirds being spent in those with obesity and NASH, according to a presentation.

There was no significant difference in results when giving finerenone with or without sodium-glucose cotransporter-2 inhibitors to patients with type 2 diabetes and chronic kidney disease, according to a speaker at ASN Kidney Week.

Menopausal hormone therapy does not affect risks for cardiovascular disease or type 2 diabetes, according to findings from a study of middle-aged postmenopausal women in South Korea published in Menopause.

Use of a glucose meter with color-coded range indicators paired with a Spanish-language mobile app reduced HbA1c in a cohort of predominantly underserved Hispanic participants with type 2 diabetes, according to study data.

SARS-CoV-2 may use ACE2 or other enzymes as a receptor to infect beta cells, providing a possible explanation behind new-onset diabetes occurring in people with COVID-19, according to a speaker.

A novel once-weekly formulation of basal insulin was safe and effective in adults with long-standing type 2 diabetes, with lower rates of documented and nocturnal hypoglycemia over 32 weeks compared with insulin degludec, phase 2 data show.

Clinicians should be cautious when prescribing certain antihyperglycemic agents for people with type 2 diabetes at risk for fracture, particularly when a patient is older with long disease duration or complications, according to a speaker.

A novel risk calculator leveraging two widely available clinical biomarkers can accurately predict heart failure hospitalization for adults with type 2 diabetes at high atherosclerotic cardiovascular disease risk, data show.

A 20% weight-loss threshold after bariatric surgery is associated with initial type 2 diabetes remission, even among patients with a high BMI using insulin, data from a records review show.

Participation in diabetes self-management support interventions may help adults with type 2 diabetes reduce depressive symptoms, according to study findings.